Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
StockNews.AI · 2 days
High Materiality8/10
Information
LAVAL, QC, Feb. 23, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global,...
Original sourceAI Summary
Bausch Health has successfully launched the Clear + Brilliant® Touch laser in Canada, following its Health Canada approval on May 20, 2025. This move taps into the growing demand for non-invasive skin rejuvenation, potentially enhancing Solta Medical's revenue and market presence in the aesthetics field.
Sentiment Rationale
The product launch aligns with growing market demand, similar to successful past launches that boosted BHC's stock.
Trading Thesis
Buy BHC as the Canadian launch may drive significant revenue growth in 2025.
Market-Moving
- The launch of the laser targets the rapidly growing aesthetic market.
- Expansion in Canada follows a successful U.S. launch, indicating strong product demand.
- Robust clinical data supporting the device may reassure investors.
- Growing consumer interest in non-invasive treatments could enhance sales growth.
Key Facts
- BHC launches Clear + Brilliant Touch laser in Canada.
- Health Canada approved the device on May 20, 2025.
- The device enhances skin rejuvenation with dual-wavelength technology.
- Solta Medical's portfolio expands in response to aesthetic demand.
- Treatment aims to meet growing preferences for non-invasive skin care.
Companies Mentioned
- Solta Medical (N/A): Solta Medical, part of BHC, leads in aesthetic technologies.
Corporate Developments
This news falls under 'Corporate Developments' as it involves a significant product launch that can alter BHC's market strategy and revenue potential within the aesthetics sector.